Fluorescence-guided resection of experimental malignant glioma using cetuximab-IRDye 800CW.

Item

http://www.wikidata.org/entity/Q36540727

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Fluorescence-guided resection ...... a using cetuximab-IRDye 800CW.

@ast

Fluorescence-guided resection ...... a using cetuximab-IRDye 800CW.

@en

type

Item

label

Fluorescence-guided resection ...... a using cetuximab-IRDye 800CW.

@ast

Fluorescence-guided resection ...... a using cetuximab-IRDye 800CW.

@en

prefLabel

Fluorescence-guided resection ...... a using cetuximab-IRDye 800CW.

@ast

Fluorescence-guided resection ...... a using cetuximab-IRDye 800CW.

@en

P1476

Fluorescence-guided resection ...... a using cetuximab-IRDye 800CW.

@en

P2093

Eben L Rosenthal

http://www.w3.org/2001/XMLSchema#string

Esther de Boer

http://www.w3.org/2001/XMLSchema#string

G Yancey Gillespie

http://www.w3.org/2001/XMLSchema#string

James M Markert

http://www.w3.org/2001/XMLSchema#string

Jason M Warram

http://www.w3.org/2001/XMLSchema#string

Joy Kovar

http://www.w3.org/2001/XMLSchema#string

Melissa Korb

http://www.w3.org/2001/XMLSchema#string

Yolanda Hartman

http://www.w3.org/2001/XMLSchema#string

P2860

Dynamic quantitative intravital imaging of glioblastoma progression reveals a lack of correlation between tumor growth and blood vessel density

Use of panitumumab-IRDye800 to image microscopic head and neck cancer in an orthotopic surgical model.

Integrin αvβ3-targeted IRDye 800CW near-infrared imaging of glioblastoma.

Fluorescently labeled therapeutic antibodies for detection of microscopic melanoma.

Establishing percent resection and residual volume thresholds affecting survival and recurrence for patients with newly diagnosed intracranial glioblastoma.

Prognostic value of residual fluorescent tissue in glioblastoma patients after gross total resection in 5-aminolevulinic Acid-guided surgery.

Fluorescence-guided resection of gliomas.

Treatment of primary glioblastoma multiforme with cetuximab, radiotherapy and temozolomide (GERT)--phase I/II trial: study protocol.

Surgery with molecular fluorescence imaging using activatable cell-penetrating peptides decreases residual cancer and improves survival.

Epidermal growth factor receptor in glioma: signal transduction, neuropathology, imaging, and radioresistance

P304

850-858

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/02688697.2015.1056090

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-06-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

278331578

http://www.w3.org/2001/XMLSchema#string

P698

26073144

http://www.w3.org/2001/XMLSchema#string

P921

cetuximab

P932

4740249

http://www.w3.org/2001/XMLSchema#string